Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Endo Pharmaceuticals has filed a lawsuit against Mylan Pharmaceuticals in the US District Court for the District of Delaware.
Subscribe to our email newsletter
The case was filed in connection with the submission of abbreviated new drug application (ANDA) for Frovatriptan Succinate EQ, 2.5mg base tablets with the US Food and Drug Administration (FDA).
Mylan‘s Frovatriptan Succinate EQ, 2.5mg base tablets are generic equivalent to Endo Pharma’s Frova which is used as a treatment of symptoms related to acute migraine headaches with or without aura, in adults.